| Value | ₹40.00 Cr |
|---|
NSE filing, NSE: KECL. Summary written from the filing by ALFA Finder's alert engine.
Kirloskar Electric Company Ltd: key numbers
- Share price
- ₹112.75
- Market cap
- ₹748.8 Cr
- Revenue (annual)
- ₹589.3 Cr
- Net profit (annual)
- ₹8.38 Cr
- P/E (TTM)
- 216.4×Sector 44.3×
- Promoter holding
- 52.23%+2.49% QoQ
- FII holding
- 4.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kirloskar Electric Company Ltd
All →Kirloskar Electric Company Q2 FY27 Results: Net Profit ₹6 Cr, Up 33.3% YoY
Kirloskar Electric Company Ltd reported revenue from operations of ₹164.4 Cr (+15.7% YoY) and net profit of ₹6 Cr (+33.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6 Cr · +33.3% YoY
Kirloskar Electric Company Board Meeting Date
Kirloskar Electric has intimated that its Board will meet on 6 November 2026 to consider Q1 and H1 FY27 unaudited results. The trading window remains closed until 48 hours post-declaration.
Kirloskar Electric Company Debt & Borrowing: ₹100 Cr
Kirloskar Electric's Board approved ₹100 Crore in Kotak Mahindra bank overdrafts, secured by a related-party FD lien. A promoter personal guarantee deed was also executed.
- Value
- ₹100.0 Cr
Kirloskar Electric Company Credit Rating
CRISIL Ratings has upgraded the credit ratings for Kirloskar Electric Company's bank loan facilities totalling ₹115.63 Crore. The long-term rating improved to Crisil BB/Stable.
- Value
- ₹115.6 Cr
Kirloskar Electric Company Other Announcement
Kirloskar Electric Company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory requirements.
Kirloskar Electric Company Other Announcement
Kirloskar Electric Company Ltd has filed its quarterly shareholding pattern disclosure as per SEBI regulations. This is a routine compliance filing.
Other preferential issue announcements
All →Aptus Pharma Preferential Issue
Aptus Pharma allotted 15,97,470 equity shares at ₹280 to 188 allottees, raising ₹44.73 Crore preferentially. Board approved the allotment on 12 November 2026.
- Value
- ₹44.73 Cr
Yatharth Hospital & Trauma Care Services Preferential Issue
Yatharth Hospital received CCI approval for its proposed ₹3,150 Crore preferential issue to Rasmalai Limited (24.87% stake). This clears a key regulatory hurdle for the capital raise.
- Value
- ₹3,150 Cr
IIFL Finance Preferential Issue
IIFL Finance's EGM on 4 December 2026 seeks approval for a preferential issue. Convertible preference shares and warrants total about ₹6,414.20 Crore.
- Value
- ₹6,414 Cr
Natural Capsules Preferential Issue
Natural Capsules added an allotment of 1,12,500 equity shares and 4,50,000 warrants to promoter Sunil Mundra to its 13 November board agenda. No issue price is stated.
IIFL Finance Preferential Issue
IIFL Finance executed three subscription agreements for a preferential issue of CCPS and warrants at Rs 602 per share. Completion is subject to shareholder and regulatory approvals.
Simplex Infrastructures Preferential Issue
Simplex Infrastructures submitted the CARE Ratings monitoring agency report for the quarter ended 30 September 2026 on its preferential issue. The report shows nil deviation from objects, with the issue aggregating Rs.423.69 crore.